Copy to clipboard 
OrthoPediatrics reported 4Q19 orthopedic revenue of USD $19 million, +30.1% vs. 4Q18, with full-year 2019 revenue of $72.6 million, +26% vs. 2018. The company drove significant growth momentum through increased unit volume. OrthoPediatrics consigned $18.2 million worth of surgical sets in 2019, a 52% increase over the prior year. The sales organization increased from 131 to 167 personnel during the year, including an expansion of international service that now includes 43 countries. The company completed its first major acquisition in June 2019 when it purchased Vilex for its Orthex fixation technology. Orthex expands OrthoPediatrics’ reach in the trauma and deformity correction market from 60% to 80%, equating to a $200 million market opportunity. The company expects revenue growth of 20% to 22% in 2020.
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
| 4Q19 | 4Q18 | $ Chg | % Chg | |
|---|---|---|---|---|
| Spine | $4.9 | $4.1 | $0.8 | 20.7% |
| Trauma | $13.6 | $10.2 | $3.5 | 34.3% |
| Sports Medicine | $0.4 | $0.4 | $0.1 | 17.8% |
| Total | $19.0 | $14.6 | $4.4 | 30.1% |
| FY 19 | FY 18 | $ Chg | % Chg | |
|---|---|---|---|---|
| Spine | $21.5 | $16.7 | $4.8 | 28.9% |
| Trauma | $49.4 | $39.7 | $9.7 | 24.4% |
| Sports Medicine | $1.7 | $1.2 | $0.5 | 41.1% |
| Total | $72.6 | $57.6 | $15.0 | 26% |
Geographic Sales
| 4Q19 | 4Q18 | $ Chg | % Chg | |
|---|---|---|---|---|
| US | $14.2 | $10.9 | $3.2 | 29.5% |
| Ex-US | $4.8 | $3.6 | $1.2 | 31.8% |
| Total | $19.0 | $14.6 | $4.4 | 30.1% |
Earnings
| Amt | % of Sales | |
|---|---|---|
| Sales | $19.0 | |
| Cost of Sales | ($4.5) | 23.8% |
| General and Admin | ($7.2) | 38.1% |
| Selling and Marketing | ($8.4) | 44.1% |
| R & D | ($1.9) | 10.1% |
| Other | ($1.3) | 6.8% |
| Net Earnings | ($4.3) | (22.8%) |
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
OrthoPediatrics reported 4Q19 orthopedic revenue of USD $19 million, +30.1% vs. 4Q18, with full-year 2019 revenue of $72.6 million, +26% vs. 2018. The company drove significant growth momentum through increased unit volume. OrthoPediatrics consigned $18.2 million worth of surgical sets in 2019, a 52% increase over the prior year. The...
OrthoPediatrics reported 4Q19 orthopedic revenue of USD $19 million, +30.1% vs. 4Q18, with full-year 2019 revenue of $72.6 million, +26% vs. 2018. The company drove significant growth momentum through increased unit volume. OrthoPediatrics consigned $18.2 million worth of surgical sets in 2019, a 52% increase over the prior year. The sales organization increased from 131 to 167 personnel during the year, including an expansion of international service that now includes 43 countries. The company completed its first major acquisition in June 2019 when it purchased Vilex for its Orthex fixation technology. Orthex expands OrthoPediatrics’ reach in the trauma and deformity correction market from 60% to 80%, equating to a $200 million market opportunity. The company expects revenue growth of 20% to 22% in 2020.
Revenue Data
All revenue data is provided in USD millions unless otherwise noted. Sales and growth rates are estimated on an as-reported basis.
Segment Sales
| 4Q19 | 4Q18 | $ Chg | % Chg | |
|---|---|---|---|---|
| Spine | $4.9 | $4.1 | $0.8 | 20.7% |
| Trauma | $13.6 | $10.2 | $3.5 | 34.3% |
| Sports Medicine | $0.4 | $0.4 | $0.1 | 17.8% |
| Total | $19.0 | $14.6 | $4.4 | 30.1% |
| FY 19 | FY 18 | $ Chg | % Chg | |
|---|---|---|---|---|
| Spine | $21.5 | $16.7 | $4.8 | 28.9% |
| Trauma | $49.4 | $39.7 | $9.7 | 24.4% |
| Sports Medicine | $1.7 | $1.2 | $0.5 | 41.1% |
| Total | $72.6 | $57.6 | $15.0 | 26% |
Geographic Sales
| 4Q19 | 4Q18 | $ Chg | % Chg | |
|---|---|---|---|---|
| US | $14.2 | $10.9 | $3.2 | 29.5% |
| Ex-US | $4.8 | $3.6 | $1.2 | 31.8% |
| Total | $19.0 | $14.6 | $4.4 | 30.1% |
Earnings
| Amt | % of Sales | |
|---|---|---|
| Sales | $19.0 | |
| Cost of Sales | ($4.5) | 23.8% |
| General and Admin | ($7.2) | 38.1% |
| Selling and Marketing | ($8.4) | 44.1% |
| R & D | ($1.9) | 10.1% |
| Other | ($1.3) | 6.8% |
| Net Earnings | ($4.3) | (22.8%) |
Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
ME
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
